These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 24965297)

  • 21. Intraperitoneal IL-6 signaling in incident patients treated with icodextrin and glucose bicarbonate/lactate-based peritoneal dialysis solutions.
    Opatrna S; Lysak D; Trefil L; Parker C; Topley N
    Perit Dial Int; 2012; 32(1):37-44. PubMed ID: 22302924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds.
    Miyata T; Horie K; Ueda Y; Fujita Y; Izuhara Y; Hirano H; Uchida K; Saito A; van Ypersele de Strihou C; Kurokawa K
    Kidney Int; 2000 Jul; 58(1):425-35. PubMed ID: 10886591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble Forms and Ligands of the Receptor for Advanced Glycation End-Products in Patients with Acute Respiratory Distress Syndrome: An Observational Prospective Study.
    Jabaudon M; Blondonnet R; Roszyk L; Pereira B; Guérin R; Perbet S; Cayot S; Bouvier D; Blanchon L; Sapin V; Constantin JM
    PLoS One; 2015; 10(8):e0135857. PubMed ID: 26274928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peritoneal accumulation of advanced glycosylation end-products in diabetic rats on dialysis with icodextrin.
    Lee JH; Reddy DK; Saran R; Moore HL; Twardowski ZJ; Nolph KD; Khanna R
    Perit Dial Int; 2000; 20 Suppl 5():S39-47. PubMed ID: 11229611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Initiating CAPD with a regimen low in glucose and glucose degradation products, with icodextrin and amino acids (NEPP) is safe and efficacious.
    le Poole CY; Welten AG; Weijmer MC; Valentijn RM; van Ittersum FJ; ter Wee PM
    Perit Dial Int; 2005 Feb; 25 Suppl 3():S64-8. PubMed ID: 16048260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products.
    Valencia JV; Mone M; Koehne C; Rediske J; Hughes TE
    Diabetologia; 2004 May; 47(5):844-52. PubMed ID: 15127201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation?
    Zeier M; Schwenger V; Deppisch R; Haug U; Weigel K; Bahner U; Wanner C; Schneider H; Henle T; Ritz E
    Kidney Int; 2003 Jan; 63(1):298-305. PubMed ID: 12472796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Septic shock is associated with receptor for advanced glycation end products ligation of LPS.
    Yamamoto Y; Harashima A; Saito H; Tsuneyama K; Munesue S; Motoyoshi S; Han D; Watanabe T; Asano M; Takasawa S; Okamoto H; Shimura S; Karasawa T; Yonekura H; Yamamoto H
    J Immunol; 2011 Mar; 186(5):3248-57. PubMed ID: 21270403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathy.
    Penfold SA; Coughlan MT; Patel SK; Srivastava PM; Sourris KC; Steer D; Webster DE; Thomas MC; MacIsaac RJ; Jerums G; Burrell LM; Cooper ME; Forbes JM
    Kidney Int; 2010 Aug; 78(3):287-95. PubMed ID: 20463655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Activation of receptor for advanced glycation end products: a mechanism for monocyte-mediated inflammation in chronic renal failure].
    Hou FF; Ren H; Guo ZJ; Chen PY; Liang M; Zhang X
    Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(19):1614-9. PubMed ID: 15569456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of chronic hypoxia on RAGE and its soluble forms in lungs and plasma of mice.
    Gopal P; Gosker HR; Theije CC; Eurlings IM; Sell DR; Monnier VM; Reynaert NL
    Biochim Biophys Acta; 2015 May; 1852(5):992-1000. PubMed ID: 25703138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects between amphoterin and advanced glycation end products on colon cancer cells.
    Kuniyasu H; Chihara Y; Kondo H
    Int J Cancer; 2003 May; 104(6):722-7. PubMed ID: 12640679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraperitoneal infusion of glucose-based dialysate in the rat--an animal model for the study of peritoneal advanced glycation end-products formation and effect on peritoneal transport.
    Zeltzer E; Klein O; Rashid G; Katz D; Korzets Z; Bernheim J
    Perit Dial Int; 2000; 20(6):656-61. PubMed ID: 11216555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-mobility group box-1 and its receptors contribute to proinflammatory response in the acute phase of spinal cord injury in rats.
    Chen KB; Uchida K; Nakajima H; Yayama T; Hirai T; Rodriguez Guerrero A; Kobayashi S; Ma WY; Liu SY; Zhu P; Baba H
    Spine (Phila Pa 1976); 2011 Dec; 36(25):2122-9. PubMed ID: 21343866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.
    Jang Y; Kim JY; Kang SM; Kim JS; Chae JS; Kim OY; Koh SJ; Lee HC; Ahn CW; Song YD; Lee JH
    Metabolism; 2007 Feb; 56(2):199-205. PubMed ID: 17224333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact on peritoneal membrane of use of icodextrin-based dialysis solution in peritoneal dialysis patients.
    Moriishi M; Kawanishi H; Tsuchiya S
    Adv Perit Dial; 2006; 22():24-8. PubMed ID: 16983933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
    Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "NEPP" peritoneal dialysis regimen has beneficial effects on plasma CEL and 3-DG, but not pentosidine, CML, and MGO.
    le Poole CY; van Ittersum FJ; Valentijn RM; Teerlink T; Lindholm B; Ter Wee PM; Schalkwijk CG
    Perit Dial Int; 2012; 32(1):45-54. PubMed ID: 21632443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycation and advanced glycation end-product formation with icodextrin and dextrose.
    Dawnay AB; Millar DJ
    Perit Dial Int; 1997; 17(1):52-8. PubMed ID: 9068023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Members of the receptor for advanced glycation end products axis as potential therapeutic targets in patients with lupus nephritis.
    Yu SL; Wong CK; Szeto CC; Li EK; Cai Z; Tam LS
    Lupus; 2015 Jun; 24(7):675-86. PubMed ID: 25411258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.